JLSB EndNote Style
Manuscript Template (MS Word)
Declaration form
Policies and Publication Ethics

Instructions for Authors


Manuscript as Original Research Paper, Review and Case Reports are invited for rapid peer-review publishing in the Journal of Life Science and Biomedicine. Considered subject areas include: biology, physiology, biochemistry, zoology, pathology... view full aims and scope

Types of contributions
Research Paper:
Please provide full author information, a set of keywords and an abstract in the title page. Supplementary materials can be published if necessary. Authors are encouraged to be concise although currently there is no length limit on research paper. Short Research Communication presents a concise study, or sometimes preliminary but innovative research findings that might be less substantial than a full research paper.
Review or mini-review
should be authoritative and of high interest. A minimum of two figures/illustrations should be included in the review or mini-review that should be some 3000 or 5000 words long (excluding references and figure legends). High quality reviews from leading researchers in their fields are particularly welcome.
Short Research Communication
is limited to 2500 words. It should have a set of keywords and an abstract summarizing background of the work, the results and their implications. Results and Discussion Section should be combined and followed by Conclusion. Materials and Methods will remain as a separate section. The number of references is limited to 30 and the number of figures and/or tables combined is limited to
Letter:
Description of novel findings that might not be suitable for a regular research paper or short research communication may be published as letter. Letter is limited to be under 500 words and 5 references. There should be not more than two figures or tables combined, and no supplementary material.


Submission

The manuscript and other correspondence should preferentially be submit online. Please embed all figures and tables in the manuscript to become one single file for submission. Once submission is complete, the system will generate a manuscript ID and password sent to author's contact emails: editors [at] jlsb.science-line.com ; jlsb.editors [at] gmail.com. All manuscripts must be checked (by English native speaker) and submitted in English for evaluation (in totally confidential and impartial way).

Supplementary information:
The online submission form allows supplementary information to be submitted together with the main manuscript file and covering letter. If you have more than one supplementary files, you can submit the extra ones by email after the initial submission. Author guidelines are specific for each journal. Our Word template can assist you by modifying your page layout, text formatting, headings, title page, image placement, and citations/references such that they agree with the guidelines of journal. If you believe your article is fully edited per journal style, please use our MS Word template before submission.

Supplementary materials may include figures, tables, methods, videos, and other materials. They are available online linked to the original published article. Supplementary tables and figures should be labeled with a "S", e.g. "Table S1" and "Figure S1".
The maximum file size for supplementary materials is 10MB each. Please keet the files as small possible to avoid the frustrations experienced by readers with downloading large files.

Submission to the Journal is on the understanding that:
1.The article has not been previously published in any other form and is not under consideration for publication elsewhere;
2.All authors have approved the submission and have obtained permission for publish work.
3.Researchers have proper regard for conservation and animal welfare considerations. Attention is drawn to the 'Guidelines for the Treatment of Animals in Research and Teaching'. Any possible adverse consequences of the work for populations or individual organisms must be weighed against the possible gains in knowledge and its practical applications. If the approval of an ethics committee is required, please provide the name of the committee and the approval number obtained.

Ethics Committee Approval
Experimental research involving human or animals should have been approved by author's institutional review board or ethics committee. This information can be mentioned in the manuscript including the name of the board/committee that gave the approval. Investigations involving humans will have been performed in accordance with the principles of Declaration of Helsinki. And the use of animals in experiments will have observed the Interdisciplinary Principles and Guidelines for the Use of Animals in Research, Testing, and Education by the New York Academy of Sciences, Ad Hoc Animal Research Committee. If the manuscript contains photos or parts of photos of patients, informed consent from each patient should be obtained. Patient's identities and privacy should be carefully protected in the manuscript.

.

1075

Graphical Abstract
Authors should provide a graphical abstract (a beautifully designed feature figure) to represent the paper aiming to catch the attention and interest of readers. Graphical abstract will be published online in the table of content. The graphical abstract should be colored, and kept within an area of 12 cm (width) x 6 cm (height) or with similar format. Image should have a minimum resolution of 300 dpi and line art 1200dpi.
Note:
Height of the image should be no more than the width. Please avoid putting too much information into the graphical abstract as it occupies only a small space. Authors can provide the graphical abstract in the format of PDF, Word, PowerPoint, jpg, or png, after a manuscript is accepted for publication.

If you have decided to provide a Professional Graphical Abstract, please click here.


alt

.

Presentation of the article


Main Format:

First page must be properly identified by the title, authors’ names and affiliations with one author clarified as the corresponding author. The full contact information (phone number and e-mail address) should be provided for this person. Tables and figures (at highest resolution) should be provided in the document in their appropriate place. For manuscript edited per journal Microsoft Word templates (.doc), Please include Tables and figures at the end of manuscript.

'Times New Roman' font 11 point size
Double spaced
A4 format with 2.5 cm margins
Automatic page numbering
Automatic line numbering:
On the Page Layout tab, in the Page Setup group, click on 'Line Numbers'. then click on "Add line numbering" and also "Continuous" Options, and OK.

Title page:

TITLE should be brief, attractive and targeted.

Names and Affiliations of authors including post code and Email. Please provide full names. Please write first name and middle name then last name, e.g., "Mike Johnson" not "Johnson, Mike"; not "Johnson M."; not "M. Johnson".

ABSTRACT should be 150 to 350 words in length. It should be informative and completely self-explanatory, briefly present the topic, state the scope of the experiments, indicate significant data, and point out major findings and conclusions. Standard nomenclature should be used and abbreviations should be avoided. No literature should be cited.

Key words shoul be about 3-6, separated by or comma.

Abbreviations (those used throughout the manuscript)


Main Text (please do not add number before subtitles):

INTRODUCTION should provide the relevant literature on the subject, and the proposed approach or solution in this regard, and clear statement of the problem directed to a brief aim of the study.

MATERIALS AND METHODS should be complete enough to allow experiments to be reproduced. Methodology includes description of the equipment and the techniques used for gathering the data of the research. The ethical approval for using human and animals in the researches should be indicated in this section with a separated title.

RESULTS should be presented with clarity and precision. In case of the effectiveness of a particular drug or other substances as inhibitor in biological or biochemical processes, the results should be provided as IC50 (half maximal inhibitory concentration) or similar appropriate manner.

DISCUSSION should interpret the findings in view of the results obtained in this and in past studies on this topic.

CONCLUSION should be brief and tight about the importance of the work or suggest the potential applications and extensions. This section should not be similar to the Abstract content.

Both 'Results and Discussion' and 'Discussion and Conclusion' can be presented jointly.

Appendix (if needed)

Declarations including Ethics, Consent to publish, Competing interests, Authors' contributions, and Availability of data and materials are necessary.

Acknowledgements of persons, grants, funds, etc should be brief.

Tables should be simply designed as possible. Double-spaced including headings and footnotes, numbered consecutively in Arabic numerals. The same data should not be presented in both table and graph forms or repeated in the text.

Figures should be numbered consecutively in Arabic numerals (Figure 1) and their parts can be identified by upper case letters (A, B, C, ...). Graphs should be prepared using applications capable of generating high resolution GIF, TIFF, JPEG or PowerPoint before pasting in the Microsoft Word manuscript file. Information given in legends should not be repeated in the text.

Insert both figures and tables as list at the end of the document. Place caption below the figure and above the table.

.

alt

Declarations

Please ensure that the sections:
-Ethics (and consent to participate)
-Consent to publish
-Competing interests
-Authors' contributions
-Availability of data and materials
are included at the end of your manuscript in a Declarations section.

Consent to Publish
Please include a ‘Consent for publication’ section in your manuscript. If your manuscript contains any individual person’s data in any form (including individual details, images or videos), consent to publish must be obtained from that person, or in the case of children, their parent or legal guardian. All presentations of case reports must have consent to publish. You can use your institutional consent form or our consent form if you prefer. You should not send the form to us on submission, but we may request to see a copy at any stage (including after publication). If your manuscript does not contain any individual persons data, please state “Not applicable” in this section.

Authors’ Contributions
For manuscripts with more than one author, JLSB require an Authors' Contributions section to be placed after the Competing Interests section. An 'author' is generally considered to be someone who has made substantive intellectual contributions to a published study. To qualify as an author one should 1) have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) have been involved in drafting the manuscript or revising it critically for important intellectual content; and 3) have given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship.
We suggest the following format (please use initials to refer to each author's contribution): AB carried out the molecular genetic studies, participated in the sequence alignment and drafted the manuscript. JY carried out the immunoassays. MT participated in the sequence alignment. ES participated in the design of the study and performed the statistical analysis. FG conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
For authors that equally participated in a study please write 'All/Both authors contributed equally to this work.' Contributors who do not meet the criteria for authorship should be listed in an acknowledgements section.

Competing interests
Competing interests that might interfere with the objective presentation of the research findings contained in the manuscript should be declared in a paragraph heading "Competing interests" (after Acknowledgment section and before References). Examples of competing interests are ownership of stock in a company, commercial grants, board membership, etc. If there is no competing interest, please use the statement "The authors declare that they have no competing interests.".

alt

Journal of Life Science and Biomedicine adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). According to the ICMJE authorship criteria should be based on 1) substantial contributions to conception and design of, or acquisition of data or analysis and interpretation of data, 2) drafting the article or revising it critically for important intellectual content and 3) final approval of the version to be published. Authors should meet conditions 1, 2 and 3.
It is a requirement that all authors have been accredited as appropriate upon submission of the manuscript. Contributors who do not qualify as authors should be mentioned under Acknowledgements.

Change in authorship
We do not allow any change in authorship after provisional acceptance. We cannot allow any addition, deletion or change in sequence of author name. We have this policy to prevent the fraud.

Acknowledgements
We strongly encourage you to include an Acknowledgements section between the Authors’ contributions section and Reference list. Please acknowledge anyone who contributed towards the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content, but who does not meet the criteria for authorship. Please also include their source(s) of funding. Please also acknowledge anyone who contributed materials essential for the study.
Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements. Please list the source(s) of funding for the study, for each author, and for the manuscript preparation in the acknowledgements section. Authors must describe the role of the funding body, if any, in study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.

Data Deposition
Nucleic acid sequences, protein sequences, and atomic coordinates should be deposited in an appropriate database in time for the accession number to be included in the published article. In computational studies where the sequence information is unacceptable for inclusion in databases because of lack of experimental validation, the sequences must be published as an additional file with the article.


alt

REFERENCES

A reference style for EndNote may be found here. References should be numbered consecutively and cited in the text by number in square brackets [1, 2] (not by author and date). References should not be formatted as footnotes. Avoid putting personal communications and unpublished observations as references. All the cited papers in the text must be listed in References. All the papers in References must be cited in the text. Where available, URLs for the references should be provided.

Examples (at the text):
Smit [1] ...; Smit and Janak [2]…; Nurai et al. [3]
reported that ; ... [1], --- [2, 3], --- [3-7].
The references at the end of this document are in the preferred referencing style. Give all authors’ names; do not use “et al.” unless there are six authors or more. Use a space after authors’ initials. Papers that have not been published should be cited as “unpublished”. Papers that have been accepted for publication, but not yet specified for an issue should be cited as “to be published”. Papers that have been submitted for publication should be cited as “submitted for publication”. Capitalize only the first word in a paper title, except for proper nouns and element symbols. For papers published in translation journals, please give the English citation first, followed by the original foreign-language citation.

Examples (at References section):
For Journals
:
1.
Sukiman F, Imy SC and Hilman A. 2014. Short Communication: Growth of Seaweed Eucheuma cottonii in Multitrophic Sea Farming Systems at Gerupuk Bay, Central Lombok, Indonesia. Bioscience. 6(1): 82-85.

2.
Hasan V, Sri Widodo M and Semedi B. 2015. Oocyte Diamater Distribution and Fecundity of Javaen Barb (Systomus Orphoides) at the Start of Rainy Season in Lenteng River, East Java, Indonesia insurance. J. Life Sci. Biomed. 5(2): 39-42.

For In press manuscripts (maximum 2):
Hasan V, Sri Widodo M and Semedi B. 2015. Oocyte Diamater Distribution and Fecundity of Javaen Barb (Systomus Orphoides) at the Start of Rainy Season in Lenteng River, East Java, Indonesia insurance. In press.

For symposia reports and abstracts:
Cruz EM, Almatar S, Aludul EK and Al-Yaqout A (2000). Preliminary Studies on the Performance and Feeding Behaviour of Silver Pomfret (Pampus argentens euphrasen) Fingerlings fed with Commercial Feed and Reared in Fibreglass Tanks. Asian Fisheries Society Manila, Philippine 13: 191-199.

For Conference:
Skinner J, Fleener B and Rinchiuso M. 2003. Examining the Relationship between Supervisors and Subordinate Feeling of Empowerment with LMX as A Possible Moderator. 24th Annual Conference for Industrial Organizational Behavior.

For Book:
Russell, Findlay E, 1983. Snake Venom Poisoning, 163, Great Neck, NY: Scholium International. ISBN 0-87936-015-1.

For Web Site:
Bhatti SA and Firkins JT. 2008. http://www.ohioline.osu.edu/sc1156_27.hmtl.

.

Nomenclature and Abbreviations:
Nomenclature should follow that given in NCBI web page and Chemical Abstracts. Standard abbreviations are preferable. If a new abbreviation is used, it should be defined at its first usage. Abbreviations should be presented in one paragraph, in the format: "term: definition". Please separate the items by ";".
E.g. ANN: artificial neural network; CFS: closed form solution; ...

Abbreviations of units should conform with those shown below:

Decilitre dl Kilogram kg
Milligram mg hours h
Micrometer mm Minutes
min
Molar mol/L Mililitre ml
Percent
%

Other abbreviations and symbols should follow the recommendations on units, symbols and abbreviations: in “A guide for Biological and Medical Editors and Authors (the Royal Society of Medicine London 1977).
Papers that have not been published should be cited as “unpublished”. Papers that have been accepted for publication, but not yet specified for an issue should be cited as “to be published”. Papers that have been submitted for publication should be cited as “submitted for publication".


Formulae, numbers and symbols

  1. Typewritten formulae are preferred. Subscripts and superscripts are important. Check disparities between zero (0) and the letter 0, and between one (1) and the letter I.
  2. Describe all symbols immediately after the equation in which they are first used.
  3. For simple fractions, use the solidus (/), e.g. 10 /38.
  4. Equations should be presented into parentheses on the right-hand side, in tandem.
  5. Levels of statistical significance which can be used without further explanations are *P < 0.05, **P < 0.01, and ***P < 0.001.
  6. In the English articles, a decimal point should be used instead of a decimal comma.
  7. Use Symbol fonts for "±"; "≤" and "≥" (avoid underline).
  8. In chemical formulae, valence of ions should be given, e.g. Ca2+ and CO32-, not as Ca++ or CO3.
  9. Numbers up to 10 should be written in the text by words. Numbers above 1000 are recommended to be given as 10 powered x.
  10. Greek letters should be explained in the margins with their names as follows: Αα - alpha, Ββ - beta, Γγ - gamma, Δδ - delta, Εε - epsilon, Ζζ - zeta, Ηη - eta, Θθ - theta, Ιι - iota, Κκ - kappa, Λλ - lambda, Μμ - mu, Νν - nu, Ξξ - xi, Οο - omicron, Ππ - pi, Ρρ - rho, Σσ - sigma, Ττ - tau, Υυ - ipsilon, Φφ - phi, Χχ - chi, Ψψ - psi, Ωω - omega.Please avoid using math equations in Word whenever possible, as they have to be replaced by images in xml full text.

.

alt


Review/Decisions/Processing/Policy

Firstly, all manuscripts will be checked by ​Docol©c​, a plagiarism finding tool. The received papers with plagiarism rate of more than 30% will be rejected. Manuscripts that are judged to be of insufficient quality or unlikely to be competitive enough for publication will be returned to the authors at the initial stage. The remaining manuscripts go through a single-blind review process by external reviewers selected by section editor of JLSB, who are research workers specializing in the relevant field of study. One unfavourable review means that the paper will not be published and possible decisions are: accept as is, minor revision, major revision, or reject. The corresponding authors should submit back their revisions within 14 days in the case of minor revision, or 30 days in the case of major revision. Manuscripts with significant results are typically published at the highest priority. The editor who received the final revisions from the corresponding authors shall not be hold responsible for any mistakes shown in the final publication.

Plagiarism
There is an instant policy towards plagiarism (including self-plagiarism) in our journals. Manuscripts are screened for plagiarism by ​Docol©c, before or during publication, and if found they will be rejected at any stage of processing. If we discovered accidental duplicates of published article(s) that are determined to violate our journal publishing ethics guidelines (such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like), the article will be “Withdrawn” from SCIENCELINE database. Withdrawn means that the article content (HTML and PDF) is removed and replaced with a HTML page and PDF simply stating that the article has been withdrawn according to the Scienceline Policy on Published Article Withdrawal.

Date of issue
All accepted articles are published biomonthly around 25th of January, March, May, July, September and November, each year in full text on the internet.

Publication charges
Articles of Journal of Life Science and Biomedicine are freely accessible. No submission and peer-reviewing charges are required. Publication of short reports and letter are free of charge; however, a negligible editor fee (100 USD) will be applied for long research and review papers before copyediting and publication. Instruction for payment is sent during publication process as soon as manuscript is accepted.

The Waiver policy
The submission fee will be waived for invited authors, authors of hot papers, and corresponding authors who are editorial board members of the Journal of Life Science and Biomedicine. The Journal will consider requests to waive the fee for cases of financial hardship (for high quality manuscripts and upon acceptance for publication). Requests for waiver of the submission fee must be submitted via individual cover letter by the corresponding author and cosigned by an appropriate institutional official to verify that no institutional or grant funds are available for the payment of the fee. Letters including the manuscript title and manuscript ID number should be sent to: editors [at] jlsb.science-line.com. It is expected that waiver requests will be processed and authors will be notified within two business day.

The OA policy
Journal of Life Science and Biomedicine is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of Open Access. The journal also allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.

.




(Revised on 26 February 2017)


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.